AcelRx Pharmaceuticals Inc.

(ACRX) Trade

By |

Profile

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The company's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA (sufentanil sublingual tablet) known as DZUVEO in Europe indicated for the management of acute pain, severe enough to require an opioid analgesic for adult patients and one product candidate, Zalviso (sufentanil sublingual tablet system, SST system being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings.

Contact Information

Website: www.acelrx.com
Email: investors@acelrx.com
Main Phone: +1 650 216-3500
Address: 351 Galveston Drive
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: NSD
CEO: Vincent J. Angotti
Employees: 90
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

Profile

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The company's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA (sufentanil sublingual tablet) known as DZUVEO in Europe indicated for the management of acute pain, severe enough to require an opioid analgesic for adult patients and one product candidate, Zalviso (sufentanil sublingual tablet system, SST system being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings.

Contact Information

Website: www.acelrx.com
Email: investors@acelrx.com
Main Phone: +1 650 216-3500
Address: 351 Galveston Drive
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: NSD
CEO: Vincent J. Angotti
Employees: 90
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

$ 1.88 $ 0.01 (0.53%)
Last Price 1.88 Change $ 0.01 Change % 0.53 Tick N/A
Bid 1.50 Bid Size 100.00 Ask 2.47 Ask Size 500.00
Open 1.86 High 1.92 Low 1.85 Prev Close 1.87
Last Trade Volume 377,320 52 Wk Hi 4.10 52 Wk Low 1.64
Market Cap 149.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 79,573,001.00 EPS (TTM) -0.66 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 18
Number of Buys 3 11
Number of Sells 4 7
Net Activity -9357041 -10146529
Last 10 Buys Shares
Mark G. Edwards 1,000
Mark G. Edwards 1,000
Raffi Asadorian 1,000
Mark G. Edwards 1,000
Raffi Asadorian 1,000
Raffi Asadorian 1,000
Vincent J. Angotti 1,000
Mark G. Edwards 1,000
Pamela Palmer 1,000
Mark G. Edwards 1,000
Last 10 Sell Shares
Lawrence Hamel 1,000
Lawrence Hamel 1,000
Edelman Joseph 1,000
Mark A. Wan 1,000
Mark A. Wan 1,000
Mark A. Wan 1,000
Mark A. Wan 1,000
Mark A. Wan 1,000
Mark A. Wan 1,000
Mark A. Wan 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 6 7
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 4.83 4.83 4.5 4.83
Standard Deviation 2.25 2.25 1.8 2.25
Date of Most Recent Estimate 05/29/18 05/29/18 05/10/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 2